Unresolved disorder model. using A
ATOM   1124  CG APHE   139      32.357 -15.681   8.733  0.50 33.03           C  
Unresolved disorder model. using A
ATOM   1125  CG BPHE   139      30.663 -15.331   8.814  0.50 36.07           C  
Unresolved disorder model. using A
ATOM   1126  CD1APHE   139      31.994 -16.858   9.374  0.50 32.96           C  
Unresolved disorder model. using A
ATOM   1127  CD1BPHE   139      29.444 -14.871   8.294  0.50 38.11           C  
Unresolved disorder model. using A
ATOM   1128  CD2APHE   139      33.372 -15.745   7.769  0.50 33.50           C  
Unresolved disorder model. using A
ATOM   1129  CD2BPHE   139      30.804 -16.684   9.036  0.50 38.35           C  
Unresolved disorder model. using A
ATOM   1130  CE1APHE   139      32.575 -18.083   9.015  0.50 31.30           C  
Unresolved disorder model. using A
ATOM   1131  CE1BPHE   139      28.401 -15.751   7.997  0.50 39.23           C  
Unresolved disorder model. using A
ATOM   1132  CE2APHE   139      33.961 -16.966   7.417  0.50 32.28           C  
Unresolved disorder model. using A
ATOM   1133  CE2BPHE   139      29.756 -17.563   8.740  0.50 39.03           C  
Unresolved disorder model. using A
ATOM   1134  CZ APHE   139      33.561 -18.127   8.044  0.50 31.83           C  
Unresolved disorder model. using A
ATOM   1135  CZ BPHE   139      28.563 -17.094   8.221  0.50 38.89           C  

1